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ABSTRACT 
The condition Parikartika has been mentioned in the Ayurvedic literature as one of the fifteen kinds of 
disorders which may result from an injudicious use of purgatives owing to the ignorance of the physician or 
of the patient. The acute fissure is a superficial splitting of the anoderm characterized by severe pain, 
sometimes associated with bleeding per rectum during/after defecation.  
Application of local anesthetics, anal dilatation, sphincterotomy, and fissurectomy (chronic fissure) are 
usually in practice. But these procedures have sometimes associated with some complications like post 
operative anal stenosis, sphincter incontinence etc. To overcome such problems and to provide cheap, 
simple, ambulatory and effective treatment, a combined therapy has been kept on trial on the basis of the 
treatment mentioned in the ancient literature in the management. Aim and objectives: Evaluation of 
clinical efficacy of Pichu application of Jatyadi Ghrita and Yasthimadhu Ghrita in the management of Fissure- 
in-ano (Parikartika). Materials & Methods: Taking this view in to consideration, a modified regimen with 
Jatyadi Ghrita and Yasthimadhu ghrita in Pichu form in two different groups along with Panchasakara 
churna have been kept on trial on 100 patients in each group in the Ano-Rectal Clinic of the Institute. 
Results and Conclusion: The results were assessed and compared and it was found that both the 
medicines were equally effective without any complications in the management of Fissure-in-ano. 
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INTRODUCTION 
 An anal fissure or rectal fissure, commonly known 
as Parikartika in Ayurveda, is a split in the skin of the 
distal anal canal due to stretching of the anal mucosa 
beyond its capability. The incidence of anal fissures is 
around 1 in 350 adults. The true prevalence of Anal 
fissures is unknown, but it is estimated that they account 
for 5% of Proctology referrals. They occur equally 
commonly in men and women and most often occur in 
adults aged 15 to 40. If acute they may cause pain after 
defecation but with chronic fissures pain intensity is often 
less. They will generally self-heal within a couple of weeks 
but some anal fissures become chronic and deep and will 
not heal. The most common cause of non-healing is spasm 
of the internal anal sphincter muscle which results in 
impaired blood supply to the anal mucosa. The result is a 
non-healing ulcer, which may become infected by fecal 
bacteria.  
 In adults, fissures may be caused by constipation, 
or by prolonged diarrhoea. In older adults, may be caused 
by decreased blood flow to the area. Fissures may also be 
caused by tuberculosis, occult abscesses, leukemic 
infiltrates, carcinoma, Acquired Immunodeficiency 
Syndrome (AIDS) or Inflammatory Bowel Disease, Sexually 
Transmitted Infections (syphilis, herpes, chlamydia and 
human papilloma virus). Other common causes of anal 
fissures include: childbirth trauma in women, Crohn's 
disease, Ulcerative colitis and poor toileting in young 
children.  
As per the Ayurvedic classics, on the basis of 
symptoms, the disease fissure-in-ano can be compared to 
the disease Parikartika where there is excruciating, 
cutting pain in the Basti and surrounding areas. 
“Parisarvato bhavena krintateeva chhinatteeva bastyadeeni 
iti Parikartika” 
Acharya Dalhana has described the term 
Parikartika as a condition of Guda in which there is cutting 
pain and tearing pain. According to Kasyapa the 
Parikartika is the one having cutting and tearing pain in 
Guda pradesha.[1] Similarly Jejjata and Todara have clearly 
described Parikartika as a condition which causes cutting 
pain in anorectum. The factors responsible for causation 
of Parikartika as found in various texts are Vamana-
Virechana-Vyapat, Bastikarma Vyapat, Atisara, Grahani, 
Arsha, Udavarta etc. In the similar manner it has been 
described of three types viz. Vata, Pitta and Kapha. 
Sushruta while describing the symptoms of the disease 
speaks of the features like; cutting or burning pain in anus, 
penis, umbilical region and neck of urinary bladder with 
cessation of flatus. Sushruta has mentioned Parikartika as 
a Vasti vyapad which is due to the administration of 
Ruksha vasti containing of Teekshna and Lavana dravyas in 
heavy doses.[2] According to him, it is due to Vasti netra 
vyapad which is due to inappropriate administration of 
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defective Vasti netra resulting in to cutting type of pain. [3] 
Whereas Charaka has described the features like: pricking 
pain in groins and sacral area, scanty constipated stools 
and frothy bleeding per rectum. Parikartika has been 
mentioned as Purva rupa of Arsha in Susruta samhita[4] 
and Astanga Sangraha.[5] 
According to Ayurvedic literature, there are 
several methods of treatment i.e. Bhaishaja - Kshara - Agni 
- Shastra Karma etc. Among them Bhaishaja Karma - 
medicinal treatment is the first line of treatment. However 
the Kshara, Agni & Sastra karmas have certain limitations 
and draw backs. Application of Kshara on the fissure lesion 
(Chronic) requires special equipment, skill and the 
procedure takes, a minimum period of 10-20 minutes with 
a meticulous handling. Otherwise, the spillage on the 
normal tissue can cause damage to the healthy tissues. 
Excessive penetration can lead for perianal abscess and 
fistula formation. Probably this requires surgical 
intervention. During the process of Agni karma, the 
accidental penetration deepens into the normal tissues 
amounts for infection poisoning and hematoma formation. 
This procedure is usually preceded by anal stretch. This 
leaves a large and rather uncomfortable external wound, 
which takes a long time to heal. 
 Besides Basti prayoga with different 
preparations[6-13], many authors have advocated local 
treatments like Nadi sweda, luke warm water sitz bath, 
Parisheka with cold water, milk and drugs having Kashaya 
and Sheetal guna which are aiming at Vedana shaman and 
Vrana ropana in the management of Parikartika.[14-15] 
Need for appropriate Ayurvedic Therapeutic 
approaches: Owing to the above challenges and limitation 
of different conventional approaches viz. Non-surgical 
treatments like topical nitroglycerin or calcium channel 
blockers, or injection of botulinum toxin into the anal 
sphincter, topical anesthetics etc. and Surgical treatments 
like Lateral sphincterotomy (LIS), Anal dilation or 
stretching of the anal canal (Lord's operation) etc., it is at 
this juncture that the need for drugs/measures that could 
effectively tackle Fissure-in-ano. A vast number of 
indigenous drugs approaches coupled with innumerable 
claims of their varied uses in alleviating ano rectal diseases 
calls for scientific validation for their attributes and 
principles. Various scientific studies to substantiate the 
efficacy of Ayurvedic approaches in the management of 
fissure-in-ano conducted at different Academic and 
Research Institutes including Central Council for Research 
in Ayurvedic Sciences viz. Local application of Jatyadi 
ghrita, Jatyadi taila, Anu taila, Prabhakara ghrita, Kasisadi 
Taila, Nimbadi taila, Vranaropana taila, Doorvadi ghrita, 
Vedanantaka Malahara and internal administration of 
Abhyarishta, Kutjarista, Triphala Churna etc. have proven 
an edge over the conventional therapies in managing the 
symptoms viz. pain, bleeding besides healing of ulcer. 
Adding to this the achievement of bowel regulation is 
significantly observed in all these studies indicating the 
uniqueness of Ayurvedic approaches. 
Rational of selection of trial intervention: A thorough 
review of scientific study to validate the Ayurvedic 
approaches in fissure-in-ano revealed that the Pichu 
application has not been given the emphasis. Pichu being a 
modality of drug delivery that certainly enhances the 
tissue contact time of the drug and improving the bio 
availability in comparison to conventional local application 
of drugs. Better therapeutic response over the 
conventional simple local application of drugs could be 
expected through this modality of Pichu application. 
AIM AND OBJECTIVES 
1. Evaluation of clinical efficacy of Pichu application of 
Jatyadi Ghrita and Yasthimadhu Ghrita in the 
management of Fissure- in-ano (Parikartika). 
2. Comparative analytical study of unique drug delivery 
system - Pichu application with historical controls of 
simple local application of Ayurvedic drugs from 
published literatures. 
MAERIALS AND METHODS 
Table 1 : Study Plan 
Study Type  : Interventional 
Purpose  : Treatment 
Masking  : Open label 
Timing  : Prospective 
End Point  : Efficacy  
No. of Groups  : Two 
Sample size : 200 (Group – I : 100 ; Group – II : 100) 
 
Duration of the treatment 
: Seven weeks. (Duration of the Study Period) 
 21 days (Three weeks) with treatment 
 One Month without treatment follow-up 
Centre : National Research Institute of Ayurveda Drug 
Development, Bhubaneswar, Odisha, India, 
Interventions 
 Panchasakara Churna (Siddha Yoga Sangraha); 
Jatyadi Ghrita (Astang Hridaya, Uttara sthana); 
Madhuyashti Ghrita (Bhaishajya Ratnavali Chapter 48). 
The formulations are manufactured as per the Standard 
Ayurvedic classical text in the Pharmacy section of the 
Institute. 
 
Group – I 
 Application of Jatyadi ghrita pichu preceded by 
sitz bath with luke warm water for three weeks along with 
internal administration of Panchsakara churna 5 gm at bed 
time with luke warm water for the same period. 
Group - II -Application of Yastimadhughrita Pichu daily 
preceded by sitz bath with luke warm water for three 
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weeks and internal administration of Panchsakara churna 
5 gm at bed time with luke warm water for the same 
period. 
Follow up: Four follow up observation at an interval of 
seven days, three during drug intervention followed by last 
follow up after completion of drug intervention. 
Application of Pichu (A tampoon / sterile gauze soaked in 
the Jatyadi ghrita / Yashstimadhu ghrita is placed at anus or 
anal canal Gudapichu): Initially per rectal examination is 
done while the patient is in Lithotomy position, to confirm 
the number and position of the Fissure. The sphincter tone is 
assessed with the digital examination. After giving warm 
water sitz bath for a period of 2 minutes, either Jatyadi 
ghrita or Yastimadhu ghrita pichu is kept and advised the 
patient to keep it for 2-3 hours. A ‘T’ bandage will be applied 
so that the Pichu will be retained in situ till the desired 
duration. The Pichu is applied on daily basis for 21days 
(Three weeks) or till the complete healing of the ulcer 
whichever is earlier (at OPD / IPD level) and thereafter, 
asked to visit the Ano-rectal clinic at the interval of 7 days 
for four weeks. 
Inclusion criteria 
1. Patients clinically diagnosed / confirmed by 
inspection as having Parikartika (Fissure in Ano)  
2. Patients of either sex aged between 21 and 60 years  
3. Patients of fissure-in-Ano with systemic diseases 
like Diabetes (FBS < 126 mg% / PP < 200 mg% / 
HbSAg < 6.5) and Hypertension (Systolic < 150 mm 
Hg / Diastolic < 100 mm Hg) which are well under 
control. 
4. Willing and able to participate in the study for 04 
weeks. 
Exclusion Criteria 
1. Patients having Parikartika (Fissure-in-Ano) 
secondary to Ulcerative colitis, Chron’s disease, 
Syphilis and Tuberculosis will be excluded. 
2. Patients with uncontrolled systemic disease as like 
Diabetes (FBS > 126 mg% / PP > 200 mg% / HbSAg 
> 6.5) and Hypertension (Systolic > 150 mm Hg / 
Diastolic > 100 mm Hg) will be excluded. 
3. Patients with infectious diseases like HIV and 
HbsAg will be excluded. 
4. Any other condition which the Investigator thinks 
may jeopardize the study. 
Withdrawal Criteria 
 The participant may be withdrawn from the trial if –
during the course of the trial treatment, if any serious 
condition develops/ symptoms aggravate, which 
requires urgent treatment, necessitating the 
institution of new modalities of treatment. 
OR 
 Non-compliance of the treatment regimen (minimum 
80% compliance is essential to continue in the study). 
Outcome measures: The following outcome measures 
will be recorded an interval of seven days for four weeks. 
Primary Outcome Measure 
 Change in the Clinical Parameters. 
Secondary Outcome Measures 
 Change in the bowel habit 
 Clinical safety 
Assessment Criteria 
1. Pain assessed by visual analogs scale. 
2. Status of Bleeding assessed by Examination and 
interrogation. 
3. Status of itching ani assessed by Examination and 
interrogation. 
4. Healing status of fissure assessed by physical 
examination with photographic evidence. 
Assessment Parameters 
(1) Clinical Parameters 
Visual Analogue Scale 
 
 
 
Parameters Visual analogue Scale Score 
a) Pain 
b) Bleeding 
c) Itching 
Criteria of assessment 
Table 2: Relief of Symptoms before and after treatment 
S.No. Relief/Withdrawal Description 
   1 Complete Relief Above 75 % Complete disappearance of known symptoms and absence of complications and 
Recurrence 
   2 Marked Relief Above 50% to 75% disappearance of known symptoms and absence of complications and 
Recurrence 
   3 Moderate Relief Above 50 % relief in presenting symptoms and some recurrence of fissure 
   4 Mild Relief 25 % and above relief in presenting symptoms with negligible change in the ulceration of 
fissure 
   5 No Relief No relief in presenting symptoms and no change in the ulceration of fissure 
   6 Withdrawal / 
Drop out 
1. Discontinuation of the treatment during the trial 
2. Development of any complications 
3. Aggravation of disease symptoms and 
4. Any side effect of the trial drugs 
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Table 3:  Healing status of Ulcer 
No change in Ulcer No Relief 
Partial healing Moderate Relief 
Complete healing Complete Relief 
Table 4: Gradation: Subjective Parameters 
S. No.  Symptoms  Before Treatment  After Treatment  
1  Pain  Excruciating – 5; Horrible – 4 ; Distressing– 3; 
Discomforting – 2 ; Mild – 1 ; No Pain – 0  
Excruciating – 5; Horrible – 4 ; Distressing– 
3; Discomforting – 2 ; Mild – 1 ; No Pain – 0 
2.  Bleeding  Severe – 3 ; Moderate – 2 ; Mild-1; No – 0  Severe – 3 ; Moderate – 2 ; Mild – 1 ; No – 0 
3.  Constipation  Severe – 3 ; Moderate – 2 ; Mild –1; No – 0  Severe – 3 ; Moderate – 2 ; Mild –1; No – 0  
Table 5: Gradation: Objective Parameters 
S. No.  Symptoms  Before Treatment  After Treatment  
1  Sphincter tone 
assessment  
Tightly contracted -2 
 Spasmodic -1 ; Normal-0.  
Tightly contracted -2  
Spasmodic -1 ; Normal-0.  
2.  Size of Ulcer  Big - 3 ; Medium – 2 ; Small – 1  Big - 3 ; Medium – 2 ; Small – 1; No ulcer- 0  
3.  Healing  -  Not Healing -2 ; Healing - 1 ; Completely Healed- 0  
Descriptions of the grading of the parameters 
A. Gradation of Subjective parameters 
1. Bleeding 
♦ Nil  : No bleeding 
♦ Mild   : Along with stool 
♦ Moderate  : Drop wise 6-8 drops 
♦  Severe   : About 2-3 ml 
2. Vibandha (Constipation) 
♦ No   : Passes stools regularly without difficulty 
♦ Mild   : Passes stools regularly with difficulty 
♦ Moderate  : Passes hard stools irregularly with difficulty 
♦ Severe  :Passes pellet like stool once in a week with difficulty 
B. Gradation of Objective parameters: 
1. Size of Ulcer 
♦ Nil  : No ulcer  
♦ Small   : 1mm to 4mm  
♦ Medium  : 5mm to 8mm 
♦ Big  : 9mm to 12mm 
2. Sphincter tone 
♦ Normal  
♦ Spasmodic  
♦ Tightly contracted 
3. Healing of Ulcer 
♦ Not Healing  
♦ Healing  
♦ Completely Healed  
OBSERVATIONS AND RESULTS 
Table 6: Condition of Patients on Admission 
Incidence o Condition No. of Patients Percentage (%) 
A. Age Groups (in Years): 
Age (in years) 
 
 
21-30 36 18 
31-40 92 46 
41-50 50 25 
51-60 22 11 
B. Sex 
Male 120 60 
Female 80 40 
C. Marital Status 
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  Out of 200 patients admitted for the clinical trial, 60 percent were males while 40 were females. Maximum of 46 
percent of cases fall under the age group of 31-40 yrs. while minimum of 11percent in the age up of 51-60 yrs. Among 
them about 39 percent were of Kapha prakriti followed by Pitta prakiriti with the incidence of 36 percent and Vata 
prakruti with 25 percent. Maximum no. of patients (98.5%) had constipated bowel habits and almost all patients were 
recorded as non-vegetarians (90.5 %). Married patients were reported with maximum number (86 %) and almost were 
belong to the Hindu faith. Maximum of 84 % were from the Urban area. 
Table 7: Characteristics of Fissure-in-ano (Parikartika) on Admission 
Incidence of Characteristics No. of Patients Percentage (%) 
A. Duration of illness (in days) 
Up to 365 95 47.5 
366 –730 45 22.5 
731 & above 60 30 
B. Onset of fissure 
Acute 135 67.5 
Gradual 65 32.5 
C. Severity of pain 
 
 
Mild 62 31 
Moderate 98 49 
Severe 40 20 
D. Previous H/O treatment 
Fresh 124 62 
Medical 58 29 
Operation 18 9 
E. Type of fissure 
Acute 73 36.5 
Acute on Chronic 76 38 
Chronic 51 25.5 
F. History of any Associated diseases 
Present 13 6.5 
Absent 187 93.5 
  
Married 172 86 
Unmarried 28 14 
Widow 0 0 
Divorcee 0 0 
D. Religion 
Hindu 199 99.5 
Muslim 01 0.5 
E. Habitat 
Rural 32 16 
Urban 168 84 
F. Food Habits 
Non-vegetarian 181 90.5 
Vegetarian 19 9.5 
G. Bowel Habits 
Regular 03 1.5 
Constipated 197 98.5 
H. Prakruti 
Vata 50 25 
Pitta 72 36 
Kapha 78 39 
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 About 47.5 percent of patients had the disease for at least one year and 67.5 percent patients had acute onset and 
9 percent of patients had previous anal surgery. Previous history revealed that 62 percent of patients developed afresh 
and 29 percent were underwent medical treatment for the Parikartika. The type of fissure was Acute on Chronic in 38 
percent of patients and most of the fissures (49 %) developed moderate pain. Only 6.5 percent of patients had the family 
history of the disease.  
   Table 8:  Clinical features of Fissure-in-ano (Parikartika) on Admission: 
Incidence of Clinical features No. of Patients Percentage (%) 
A. Nature of pain 
Pricking 92 46 
Cutting 29 14.5 
Throbbing 01 0.5 
Burning 78 39 
Lehing 0 0 
B. Type of Bleeding 
Persistent 0 0 
During / Defecation 104 52 
Mixed with Stool 96 48 
Malena 0 0 
C. Itching Ani (Pruritis) 
Present 105 52.5 
Absent 95 47.5 
D. Type of Edges 
Indurated 200 100 
Undermined 0 0 
A. Position (O-Clock) of Fissure-in-ano 
2 1 0.5 
3 4 2 
4 8 4 
5 20 10 
6 112 56 
7 40 20 
10 3 1.5 
11 2 1 
12 10 5 
B. Sphincter tone 
Normal 15 7.5 
Hypertonic 185 92.5 
C. Tenderness 
Present 200 100 
Absent 0 0 
 A maximum of 56 percent of fissures were positioned at 60 clock having indurated edges (100 %). All patients had 
Pain & bleeding per rectum during and after the defecation. Maximum of 39 percent had the pricking type of pain and 52 
percent of patients had itching ani. Almost all patients had Hypertonic sphincter (92.5 %) and tenderness (100 %). 
 The overall assessment of the treatment in both the groups were analysed on Subjective and Objective parameters 
and the results were summarized in the following tables. The study revealed that in both the groups, all the patients were 
having 100 % relief from the clinical features i.e., in subjective and objective parameters. The effectiveness of the 
treatment in both trial groups reveals statistically extremely significant with the ‘p’ value of <0.0001in both groups. 
Table 9 : Result of the treatment in Group – I 
Signs & Symptoms Mean +SE (BT) Follow-up Mean +SE  ‘t’ value P value Effectiveness 
A. Subjective Parameters 
1. Pain on VAS 2.556 + 0.13 AT1 0.86 + 0.14 19.16864 <0.0001 Extremely significant 
AT2 1.40 + 0.14 9.658595 <0.0001 Extremely significant 
AT3 1.97 + 0.15 13.30896 <0.0001 Extremely significant 
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2. Bleeding 1.63 + 0.05 AT1 1.63 + 0.06 10.9389 <0.0001 Extremely significant 
AT2 1.02 + 0.08 12.69006 <0.0001 Extremely significant 
AT3 0.16 + 0.06 25.49594 <0.0001 Extremely significant 
3. Constipation 1.62+ 0.04 AT1 0.82 + 0.08 10.64365 <0.0001 Extremely significant 
AT2 0.97 + 0.08 13.80036 <0.0001 Extremely significant 
AT3 1.45 + 0.06 26.01735 <0.0001 Extremely significant 
B. Objective Parameters  
4. Sphincter spasm 1.61+ 0.05 AT1 0.68 + 0.08 8.902519 <0.0001 Extremely significant 
AT2 1.01 + 0.07 14.07332 <0.0001 Extremely significant 
AT3 1.39 + 0.06 20.89993 <0.0001 Extremely significant 
5. Size of Ulcer 1.63 + 0.04 AT1 0.66 + 0.06 9.636413 <0.0001 Extremely significant 
AT2 1.11 + 0.07 15.05878 <0.0001 Extremely significant 
AT3 1.48 + 0.05 27.36403 <0.0001 Extremely significant 
6. Healing of Ulcer 1.62 + 0.04 AT1 0.73 + 0.05 12.51011 <0.0001 Extremely significant 
AT2 1.22 + 0.06 17.67627 <0.0001 Extremely significant 
AT3 1.49 + 0.05 27.53466 <0.0001 Extremely significant 
Table 10 : Result of the treatment in Group – II 
Signs & Symptoms Mean +SE (BT) Follow-up Mean +SE  ‘t’ value P value Effectiveness 
C. Subjective Parameters 
1. Pain on VAS 2.6 + 0.12 AT1 1.01 + 0.10 9.212632 <0.0001 Extremely significant 
AT2 1.53 + 0.12 12.23121 <0.0001 Extremely significant 
AT3 2.14 + 0.133 16.04818 <0.0001 Extremely significant 
2. Bleeding 1.68 + 0.04 AT1 1.64 + 0.06 10.19161 <0.0001 Extremely significant 
AT2 1.04 + 0.07 14.37204 <0.0001 Extremely significant 
AT3 1.49 + 0.05 26.63134 <0.0001 Extremely significant 
3. Constipation 1.6+ 0.04 AT1 0.68 + 0.07 8.902519 <0.0001 Extremely significant 
AT2 1.01 + 0.07 13.5518 <0.0001 Extremely significant 
AT3 1.45 + 0.06 23.7989 <0.0001 Extremely significant 
D. Objective Parameters  
4. Sphincter spasm 1.66+ 0.04 AT1 0.75 + 0.07 9.574271 <0.0001 Extremely significant 
AT2 1.08 + 0.06 16.31912 <0.0001 Extremely significant 
AT3 1.45 + 0.06 23.7989 <0.0001 Extremely significant 
5. Size of Ulcer 1.6 + 0.04 AT1 0.64 + 0.06 9.940172 <0.0001 Extremely significant 
AT2 1.11 + 0.06 15.97615 <0.0001 Extremely significant 
AT3 1.41 + 0.05 25.53319 <0.0001 Extremely significant 
6. Healing of Ulcer 1.68 + 0.04 AT1 0.79 + 0.05 13.36501 <0.0001 Extremely significant 
AT2 1.25 + 0.06 18.19017 <0.0001 Extremely significant 
AT3 1.52 + 0.05 29.12737 <0.0001 Extremely significant 
Table 11 : Overall Clinical Assessment of the therapy 
Study 
period 
Group No. of  
Patients 
 
 Overall response of the therapy 
Complete 
Relief 
Marked Relief Moderate Relief Mild Relief No Relief 
No. of Pts. % No. of Pts. % No. of Pts. % No. of Pts. % No. of Pts. % 
Before  
treatment 
Group - I 100 0 0 0 0 0 0 0 0 100 100 
Group - II 100 0 0 0 0 0 0 0 0 0 0 
7th Day of 
treatment 
Group - I 100 71 71 21 21 8 8 0 0 0 0 
Group - II 100 68 68 27 27 5 5 0 0 0 0 
14th Day of 
treatment 
Group - I 100 85 85 15 15 0 0 0 0 0 0 
Group - II 100 79 79 18 18 3 3 0 0 0 0 
21st Day of 
treatment 
Group - I 100 100 100 0 0 0 0 0 0 0 0 
Group - II 100 100 100 0 0 0 0 0 0 0 0 
Overall 
Response 
Group - I 100 100 100 0 0 0 0 0 0 0 0 
Group - II 100 100 100 0 0 0 0 0 0 0 0 
 In Group – I, the study revealed that about 71 
percent of the patients got Complete relief,  21 percent got 
marked relief while 8% got moderate relief during first 
week of the treatment i.e., by 7th day. By the end of 14th 
day 85 percent got complete relief and 15percent got 
marked relief. At the 21st day of the treatment 100 percent 
of patients got complete relief. No recurrence was 
reported during the follow-up period of four weeks after 
the completion of the treatment period of 21 days. 
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 In Group – II, the study revealed that about 68 
percent of the patients got Complete relief, 27 percent got 
marked relief while 5% got moderate relief during first 
week of the treatment i.e., by 7th day. By the end of 14th 
day 79 percent got complete relief and 18 percent got 
marked relief while 3 percent got moderate relief. At the 
end of 21st day of the treatment 100 percent of patients 
got complete relief. No recurrence was reported during the 
follow-up period of four weeks after the completion of the 
treatment period of 21 days. 
DISCUSSION  
 The objective of the study was to Evaluation of 
clinical efficacy of Pichu application of Jatyadi Ghrita and 
Yasthimadhu Ghrita in the management of Fissure- in-ano 
(Parikartika) and Comparative analytical study of unique 
drug delivery system - Pichu application with historical 
controls of simple local application of Ayurvedic drugs 
from published literatures. In this study a total number of 
200 patients were registered and were distributed in to 
two groups each containing of 100 patients each. The 
study revealed that in both the groups, all the patients 
were having 100 % relief from the clinical features i.e in 
subjective and objective parameters. The effectiveness of 
the treatment in both trial groups reveals statistically 
extremely significant with the ‘p’ value of <0.0001in both 
groups. Maximum number of patients i.e., above 70 
percent got complete relief in their clinical symptoms by 
7th day of the treatment in both the groups which 
indicates that these Ghrita preparations are highly 
effective in the management of fissure-in-ano conditions.  
Pichu -unique drug delivery system of Ayurveda:  
 Though the description about Pichu are not vividly 
available in Ayurvedic literatures, it is one of the important 
and effective modalities of drug delivery system having 
diversified applications in the management of various 
diseases /conditions viz. Siro rogas, Yoni vyapat, Karna 
roga, Nasa roga, Guda rogas owing to its unique nature of 
drug delivery and enhancing bio-availability. 
  “Pichu sthoola kavalika” - A thick swab or a cotton 
pad is called as Pichu. Pichu Dharana (placing of soaked 
linen) is a process in which a piece of cloth, gauze or linen 
is soaked in the medicated ghee or oil and placed in the 
desired position over the body or in the body parts 
according to the site of the treatment. 
Mode of Action: Local action of Pichu is based on cellular 
absorption of medicine, acts as Snehana, Lekahana etc eg: 
Vrana ropana, effective in Baghna, Nasa arsas etc. 
 Exploration of Ayurvedic and contemporary 
literature endorse various therapeutic potential of the 
formulation viz. Jatyadi ghrita, Yasthimadhu ghrita and 
Pancha sakara churna and the ingredients embodied in 
these compound formulations attributed with analgesic 
anti- inflammatory, wound healing, anti- microbial, bowel 
regulating actions. These Pivotal principles are highly 
contributory for comprehensive management of fissure-in-
ano and also to improve the quality of life. The 
combination of trial drugs in both the groups acts 
systemically as well as locally on fissure-in ano and help in 
the significant reduction of the clinical symptoms. 
 
CONCLUSION 
 Based on the descriptions available from the 
ancient classical literatures and observations made during 
the clinical study on fissure-in-ano with two drug 
combinations in two different groups which was aimed at 
assessment of clinical efficacy, the following inferences or 
conclusions can be drawn. 
 All the raw drugs used in the trial formulations were 
identified and authenticated as per the quality control 
parameters mentioned in the Ayurvedic 
Pharmacopoeia of India and manufactured as per the 
standard operative procedures laid down in Ayurvedic 
Formulary of India. The quality control parameters for 
Panchasakara churna and Yasthimadhu ghrita were 
established in association with Department of 
Pharmaceutical Analysis and Quality Assurance, 
School of Pharmaceutical Sciences, Siksha ‘O’ 
Anusandhan University, Bhubaneswar. 
 Through the descriptions on the clinical features 
available in the literature the condition - Parikartika 
can be correlated with fissure-in-ano of modern 
medical science. 
 Though the condition - Parikartika was not mentioned 
as a separate / independent disease, owing to its 
severity in clinical condition, the Parikartika can be 
taken as a separate / independent disease condition 
since many therapeutic procedures described in 
literature for its management.  
 Majority of patients were of middle aged group having 
the constipated bowel habits which can be attributed 
to their sedentary and stressful life that play the key 
role in the occurrence of the Parikartika. 
 Fissure-in-ano commonly exhibit in the midline of the 
lower quadrant of the peri-anal region and it was 
found in maximum number patients at 6 o’ clock 
position.  
 The hypertonic sphincteric spasm is commonly 
associates with acute fissure-in-ano can be relieved 
affectively by both the drug regimens. 
 The most evident symptoms present i.e., pain and 
spasm can be relieved much earlier by the application 
of Jatyadi ghrita rather than Yasthimadhu ghrita. 
 The longer the availability of the drug i.e bio-
availability of the of the Pichu form in situ (on fissure 
site), the faster the healing of the ulcer. 
 The patients treated with Jatyadi ghrita (first group) 
showed better results than Yasthimadhu ghrita as 71 
percent of patients got complete relief and 21 percent 
got marked relief during the first week while in group 
two with Yasthimadhu ghrita the complete and 
marked relief were 68 and 27 percent respectively 
during first week i.e. by 7th day of the treatment.  
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